Tailoring Therapy in Post-surgical Patients With Low-risk Endometrial Cancer
This phase II trial tests how well tailoring therapy in post-surgery works in patients
with low-risk endometrial cancer. The usual approach for patients with low-risk
endometrial cancer is treatment with surgery. In this study, tissue that is removed as
part of the s...
Age: 18 years - 66+
Gender: Female
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination with Venetoclax/Azacitidine, Venetoclax, or 7+3 in Patients with AML
This Phase 1 study will assess the safety, tolerability, and preliminary antileukemic
activity of ziftomenib in combination with venetoclax and azacitidine (ven/aza), ven, and
7+3 for two different molecularly-defined arms, NPM1-m and KMT2A-r.
Age: 18 years - 66+
Gender: All
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Ziftomenib is an investigational drug in development for the treatment of patients with
acute myeloid leukemia (AML) with certain genetic alterations.
This protocol has 3 separate arms that will investigate the benefits and risks of adding
ziftomenib to standard-of...
Age: 18 years - 66+
Gender: All
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
This study collects blood and tissue samples for research of human immunodeficiency virus
(HIV)/acquired immunodeficiency syndrome (AIDS)-related cancers. Collecting blood and
tissue samples and studying biomarkers in the laboratory may help doctors to learn how
are ...
Age: 18 years - 66+
Gender: All
Trial of Ixazomib for Kaposi Sarcoma
This phase II trial studies how well ixazomib works in treating patients with Kaposi
sarcoma. Ixazomib may stop the growth of tumor cells by blocking some of the enzymes
needed for cell growth.
Age: 18 years - 66+
Gender: All
Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
To evaluate the safety and tolerability of sotorasib administered in investigational
regimens in adult participants with KRAS p.G12C mutant advanced solid tumors.
Age: 18 - 100 years
Gender: All
Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
To evaluate the safety and tolerability of sotorasib administered in investigational regimens
in adult participants with KRAS p.G12C mutant advanced solid tumors.
Age: 18 - 100 years
Gender: All
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery
This randomized phase II/III trial studies how well pazopanib hydrochloride, combination
chemotherapy, and radiation therapy work and compares it to radiation therapy alone or in
combination with pazopanib hydrochloride or combination chemotherapy in treating patients...
Age: 2 years - 66+
Gender: All
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
Background:
- Laboratory investigators who are studying common childhood cancers are interested in
developing a tissue repository to collect and store blood, serum, tissue, urine, or
tumors of children who have cancer or adults who have common childhood cancers. To...
Age: 4 weeks - 66+
Gender: All
Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies
Background:
- Laboratory investigators who are studying common childhood cancers are interested in
developing a tissue repository to collect and store blood, serum, tissue, urine, or
tumors of children who have cancer or adults who have common childhood cancers. To...
Age: 4 weeks - 66+
Gender: All